HER-2 POSITIVE BREAST CANCER
Clinical trials for HER-2 POSITIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new HER-2 POSITIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for HER-2 POSITIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to boost breast cancer treatment before surgery
Disease control Recruiting nowThis study is for adults with a certain type of breast cancer (HER2-positive and hormone receptor-positive). It tests whether adding hormone therapy to the usual chemotherapy and HER2-targeted therapy before surgery can improve how well the tumor shrinks. About 30 participants wi…
Matched conditions: HER-2 POSITIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Legacy Health System • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New hope for tough breast cancer: A166 trial targets resistant tumors
Disease control Recruiting nowThis study tests a new drug called A166 in people with HER2-positive breast cancer that has spread and no longer responds to certain prior treatments. About 40 adults will receive A166 to see if it can shrink tumors or slow the disease. The goal is to find a better option for pat…
Matched conditions: HER-2 POSITIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 19, 2026 12:00 UTC